OTC · Medical - Instruments & Supplies

Fielmann AG (FLMNF) Stock

$50.75 +0.00% OTC: FLMNF Healthcare

Fielmann Aktiengesellschaft, together with its affiliated companies, specializes in both investing in and operating businesses within the optical and audiological sectors. The firm is responsible for the production and sale of a wide array of visual aids, including spectacles, frames, corrective lenses, sunglasses, contact lenses, and their associated accessories, along with various other general merchandise.

Valuation

MetricValue
Price$50.75
Market Cap$4.26B
P/E Ratio15.87
P/B Ratio3.32
P/S Ratio1.34
EPS (TTM)$3.20
52-Week High$64.00
52-Week Low$50.75
Dividend Yield3.15%

Financials & Margins

MetricValue
ROE21.23%
ROA7.66%
ROCE0.00%
Gross Margin27.23%
Operating Margin19.39%
Net Margin8.45%
Debt/Equity0.90
Current Ratio1.19

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.7B$1.8B$2.0B$2.3B$2.4B
Operating Profit$584.0M$576.0M$649.0M$342.0M$323.0M
Net Profit$137.0M$104.0M$125.0M$152.0M$204.0M
EPS$1.63$1.23$1.49$1.81$2.43
Op Margin34.8%32.7%33.0%15.1%13.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.7B$1.8B$2.0B$2.4B$2.7B
Total Liabilities$863.0M$913.0M$1.1B$1.5B$1.7B
Cash$175.0M$51.0M$59.0M$94.0M$222.0M
Borrowings$458.0M$506.0M$592.0M$874.0M$880.0M

Latest News

If EPS Growth Is Important To You, Fielmann Group (ETR:FIE) Presents An Opportunity Simply Wall St. · Apr 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$347.0M$268.0M$283.0M$410.0M$465.0M
Investing Cash Flow$-161.0M$-245.0M$-230.0M$-414.0M$-229.0M
Financing Cash Flow$-100.0M$-106.0M$25.0M$137.0M$-411.0M
Net Cash Flow$71.0M$-124.0M$8.0M$35.0M$139.0M
Free Cash Flow$260.0M$183.0M$196.0M$327.0M$352.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.57
EV / EBITDA6.19
FCF Yield0.00%
Quick Ratio0.80
Interest Coverage12.30
Return 1Y-18.45%
Return 3Y-0.47%
Return 5Y

Ownership

Insiders Held72.91%
Institutions Held10.42%
Institutions Float Held38.46%
Institutional HolderSharesReport Date
Gardner Russo & Quinn, LLC33,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADDLFAddLife AB (publ) $15.75 +0.00% 31.84 $1.85B 1.02%
AHICFAsahi Intecc Co., Ltd. $21.41 +0.00% 29.51 $5.68B 1.31%
CLCGYClicks Group Limited $26.95 -3.41% 15.54 $3.15B 2.37%
CNVVFConvaTec Group Plc $2.95 +4.61% 32.81 $5.75B 3.73%
CNVVYConvaTec Group Plc $11.70 +0.97% 32.81 $5.72B 3.68%

About Fielmann AG

Fielmann Aktiengesellschaft, together with its affiliated companies, specializes in both investing in and operating businesses within the optical and audiological sectors. The firm is responsible for the production and sale of a wide array of visual aids, including spectacles, frames, corrective lenses, sunglasses, contact lenses, and their associated accessories, along with various other general merchandise. Additionally, Fielmann provides hearing aids and their complementary accessories. By December 31, 2021, the company had established a significant retail presence, managing 693 stores across Europe. This extensive network comprised 610 outlets in Germany, 45 in Switzerland, 38 in Austria, 3 in Luxembourg, 43 in Italy, 37 in Poland, 87 in Spain, 32 in Slovenia, and an additional 15 locations spread throughout the rest of Europe. Furthermore, Fielmann operated 78 smaller retail points specifically in Eastern Europe. Beyond its physical stores, the company also makes its product selection available through online retail channels. Established in 1972 and based in Hamburg, Germany, Fielmann Aktiengesellschaft operates as a subsidiary under the ownership of Korva SE.

Fielmann AG is headquartered in DE.

Fielmann AG (FLMNF) stock trades at $50.75 with a market capitalization of $4.26B. The stock is valued at a price-to-earnings (P/E) ratio of 15.87, price-to-book of 3.32, price-to-sales of 1.34. Over the past 52 weeks the stock has ranged between $50.75 and $64.00, and currently trades 20.7% below its 52-week high. It pays a dividend yielding 3.15%.

On profitability, Fielmann AG generates a return on equity (ROE) of 21.23% — well above the market average, a sign of a high-quality business, return on capital employed of 0.00%, an operating margin of 19.39%, a net profit margin of 8.45%.

Official website: www.fielmann-group.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides